You are looking at 121 - 130 of 4,534 items for

  • Refine by Access: All x
Clear All
Full access

HSR24-142: Real-World Clinical Benefit Among Patients (pts) With Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated With Luspatercept

Kashyap Patel, Brandy Snyder, Derek Tang, Debanjana Chatterjee, Anupama Vasudevan, Uchechukwu Mordi, Harvey Katzen, John Li, Lindsay Aton, and Ali McBride

Full access

HSR24-143: Impact of Frailty on Hospital Outcomes Among Patients With Hemophagocytic Lymphohistiocytosis Who Received Autologous Stem Cell Transplantation in the United States

Michael Imeh, Ani Gvajaia, Chukwunonye Amaeshi, Chiamaka Nwachukwu, and Fidelis Uwumiro

Full access

HSR24-144: Does Immunotherapy Work in Patients With Poor Performance Status?

Maya Gogtay, Omar Khaled Abughanimeh, and Benjamin A. Teply

Full access

HSR24-145: Prevalence of Anxiety and Depression in Newly-Diagnosed Breast Cancer Patients in Rural Minnesota

Dhauna Karam Prasad, Mina Hanna, Timothy F. Kozelsky, and Scott H. Okuno

Full access

HSR24-146: Chemotherapy-Induced Febrile Neutropenia (FN) in the US: Healthcare Resource Utilization (HCRU) and Costs

Edward Li, Marie Yasuda, Jeanine Flanigan, and Chi‐Chang Chen

Full access

HSR24-147: Non-Optimal Treatment in Early-Line Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Tyrosine Kinase Inhibitors (TKI): A Claims Data Analysis

Vamsi Kota, David Wei, Daisy Yang, Hela Romdhani, Dominick Latremouille-Viau, Annie Guérin, and Kejal Jadhav

Full access

HSR24-148: Outcome of Positron Emission Tomography–Computed Tomography Staging in Breast Cancer Patients Having Neo-Adjuvant Systemic Therapy

Raouef Ahmed Bichoo, Mohammed Bilal Elahi, Naila Bint Ihsan, Dorin Dumitru, Brendan Wooler, Peter Kneeshaw, MB ChB, and Kartikae Grover

Full access

HSR24-149: Mobile Health (mHealth) Interventions for Colorectal Cancer (CRC) Survivors: A Systematic Review

Cheongin Im, Megan C. Thomas Hebdon, Namuun E Clifford, and Carolyn Phillips

Full access

HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States

Xiaoqin Yang, Rose Chang, Theresa Dettling, Raj Desai, Chi Gao, Azeem Banatwala, Sydney Ng, Sama Ahsan, and Mei Sheng Duh

Full access

HSR24-152: Patient-Reported Outcome (PRO) Data in Oncology NDAs Approved by the FDA (2018–2021): A Review of Criticism and Concerns in Comments From Regulators

Erin Comerford, Lindsey Norcross, Medha Sasane, Ying Zheng, and Ari Gnanasakthy